Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Based on application, the GLP-1 receptor agonist market is classified into obesity, type 2 diabetes mellitus, and other applications
Wegovy is administered as a once-weekly subcutaneous injection and is intended for use alongside a reduced-calorie diet and increased physical activity
Both contain semaglutide, but Wegovy is specifically approved and formulated for weight loss with higher maximum doses (2.4 mg vs 1 mg for Ozempic)
Instead, patients are advised to eat a diet consisting of foods that are high in fibre and rich in protein
US$ 21.98
US$ 26.92
US$ 29.17
